Stock SANION SANA AB
Add to a list
To use this feature you must be a member
Log inSign up

Highlights SANA AB

Equities

SANION

SE0005794617

Market Closed - Nasdaq Stockholm
Other stock markets
 17:00:00 20/06/2024 BST 		5-day change 1st Jan Change
3.395 SEK -9.47% Intraday chart for SANA AB -17.80% -15.34%
06-13 Transcript : Saniona AB - Special Call
05-29 Saniona AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Saniona AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Terna in first quarter increases profit and revenues by double digits
AN
Saniona AB Reports Progress on Pipeline and Other Activities
CI
Imprendiroma, indicators increase to triple digits in 2023
AN
BasicNet, revenues fall in first quarter; Ebitda down double digits
AN
Digital Value in 2023 increases revenues by 20 percent; up profit
AN
Sana Biotechnology Shares Rise as Q4 Non-GAAP Net Loss Narrows
MT
Sana Biotechnology Q4 Non-GAAP Net Loss Narrows; Cash, Cash Equivalents Decline
MT
Saniona AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Saniona AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Israeli missile attack hits high-security district in Syrian capital
RE
Saniona Announces the Selection of Its Proprietary GABAA A5 Negative Allosteric Modulator Lead Compound, San2465
CI
Saniona AB Strengthens Epilepsy Pipeline with Selection of SAN2355 as Clinical Candidate
CI
Saniona and Boehringer Ingelheim Extend Research Term with Up to Two Years
CI
Saniona AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Saniona Promotes Kv7 Epilepsy Compound to Candidate Selection Phase
CI
Saniona Announces Positive Preclinical Data on Saniona's SAN711 in Epilepsy Presented at SfN
CI
Saniona AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Saniona, AstronauTx Partner on Study of Alzheimer's, Neurodegenerative Conditions
MT
Saniona Enters into Collaboration Agreement with Astronautx in Alzheimer's Disease
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SANION Stock
  4. News SANA AB
  5. Highlights